Ultragenyx Pharmaceutical Inc. - 8-K Filing
Ultragenyx settles patent litigation with Navinta over DOJOLVI generic version; generic entry allowed starting January 1, 2033. (Items: 8.01 Other Events)
Tickers: $RARE
More Regulatory news
- Newton Golf Company, Inc. - 10-Q Filing
- XBiotech Inc. - 10-Q Filing
- Cohen & Co Inc. - 10-Q Filing
- UNITED BANCORP INC /OH/ - 10-Q Filing
- PATRIOT GOLD CORP - 10-Q Filing
- First Digital Acquisition Corp Ltd. - 8-K Filing
- GROOVE BOTANICALS INC. - 10-Q Filing
- Johnson Controls International plc - 10-K Filing
- OLD NATIONAL BANCORP /IN/ - 8-K Filing
- AMTECH SYSTEMS INC - 8-K Filing